Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer

Decera Clinical Education Oncology Podcast · Jun 30, 2021 · 7m

In this episode, Wassim Abida, MD, PhD; Joaquin Mateo, MD, PhD; and Charles J. Ryan, MD, answer questions from an audience of healthcare professionals on topics related to prostate cancer and PARP inhibition including:

Germline and somatic mutation testing

PARP inhibition in earlier stage disease

PARP inhibitors plus AR-targeted therapy after progression on AR-targeted therapy

PARP inhibition in taxane-sensitive patients

Presenters:

Wassim Abida, MD, PhD

Assistant Member

Assistant Attending Physician

Genitourinary Oncology Service

Department of Medicine

Memorial Sloan Kettering Cancer Center…